Henoch-Schönlein Purpurasının Ciddiyetini Öngörmek: Fonksiyonel Trombosit Belirteçlerinin Rolü
Amaç: Amacımız tanı anında saptanan kalitatif trombosit belirteçlerinin Henoch-Schönlein purpurası’ndaki (HSP) hastalık şiddeti ve gidişatının belirlenmesindeki yeterliliğinin değerlendirilmesidir.
Predicting the Severity of Henoch–Schönlein Purpura: The Role of the Functional Platelet Indices
Objecive: Our aim is to measure the discriminative competency of the qualitative platelet indices obtained at the time of diagnosis on the severity and outcome of Henoch-Schönlein purpura (HSP).
___
- 1. Gardner-Medwin JM, Dolezalova P, Cummins C, Southwood TR. Incidence of Henoch–Schonlein purpura, Kawasaki disease, and rare vasculitides in children of different ethnic origins. Lancet. 2002;360:1197-1202.
- 2. Çakıcı EK, Gür G, Yazılıtaş F, ve ark. A retrospective analysis of children with Henoch-Schonlein purpura and re-evaluation of renal pathologies using Oxford classification. Clin Exp Nephrol. 2019;23(7):939-947. doi: 10.1007/s10157-019-01726-5
- 3. Elmas AT, Tabel Y. Platelet Counts in Children with Henoch-Schonlein Purpura Relationship to Renal Involvement. J Clin Lab Anal. 2016;30(1):71-74.
- 4. Thompson CB, Eaton KA, Princiotta SM, Rushin CA, Valeri CR. Size dependent platelet subpopulations: relationship of platelet volume to ultrastructure, enzymatic activity, and function. Br J Haematol. 1982;50(3):509-519.
- 5. Bowles KM, Cooke LJ, Richards EM, Baglin TP. Platelet size has diagnostic predictive value in patients with thrombocytopenia. Clin Lab Haematol. 2005;27(6):370-373.
- 6. Makay B, Türkyilmaz Z, Duman M, Unsal E. Mean platelet volume in Henoch-Schönlein purpura: relationship to gastrointestinal bleeding. Clin Rheumatol. 2009;28(10):1225-1228.
- 7. Ozen S, Ruperto N, Dillon MJ, ve ark. EULAR/PReS endorsed consensus criteria for the classification of childhood vasculitides. Ann Rheum Dis. 2006;65(7):936-941.
- 8. De Mattia D, Penza R, Giordano P, ve ark. von Willebrand factor and factor XIII in children with Henoch-Schonlein purpura. Pediatr Nephrol. 1995;9(5):603-605.
- 9. Muslu A, Islek I, Gok F, ve ark. Endothelin levels in Henoch-Schonlein purpura. Pediatr Nephrol. 2002;17(11):920-925.
- 10. Fessatou S, Nicolaidou P, Gourgiotis D, ve ark. Endothelin 1 levels in relation to clinical presentation and outcome of Henoch Schonlein purpura. BMC Pediatr. 2008;8:33.
- 11. Kisacik B, Tufan A, Kalyoncu U, ve ark. Mean platelet volume (MPV) as an inflammatory marker in ankylosing spondylitis and rheumatoid arthritis. Joint Bone Spine. 2008;75(3):291-294.
- 12. Kapsoritakis AN, Koukourakis MI, Sfiridaki A, ve ark. Mean platelet volume: a useful marker of inflammatory bowel disease activity. Am J Gastroenterol. 2001;96(3):776-781.
- 13. Yüksel O, Helvaci K, Başar O, ve ark. An overlooked indicator of disease activity in ulcerative colitis: mean platelet volume. Platelets. 2009;20(4):277-281.
- 14. Culic S, Jakl R, Metlicic V, ve ark. Platelet function analysis in children with Schönlein-Henoch syndrome. Arch Med Res. 2001;32(4):268-72.
- 15. Collins CE, Rampton DS, Rogers J, Williams NS. Platelet aggregation and neutrophil sequestration in the mesenteric circulation in inflammatory bowel disease. Eur J Gastroenterol Hepatol. 1997;9:1213-1217.
- 16. Rostoker G, Rymer JC, Bagnard G, Petit-Phar M, Griuncelli M, Pilatte Y. Imbalances in serum proinflammatory cytokines and their soluble receptors: a putative role in the progression of idiopathic IgA nephropathy (IgAN) and Henoch-Schonlein purpura nephritis, and a potential target of immunoglobulin therapy? Clin Exp Immunol. 1998;114(3):468-476.
- 17. Wu TH, Wu SC, Huang TP, Yu CL, Tsai CY: Increased excretion of tumor necrosis factor alpha and interleukin 1 beta in urine from patients with IgA nephropathy and Henoch-Schonlein purpura. Nephron. 1996;74(1):79-88.
- 18. Gasparyan AY, Sandoo A, Stavropoulos-Kalinoglou A, Kitas GD. Mean platelet volume in patients with rheumatoid arthritis: the effect of anti-TNF-α therapy. Rheumatol Int. 2010;30(8):1125-1129.
- 19. van Gameren MM, Willemse PH, Mulder NH, ve ark. Effects of recombinant human interleukin-6 in cancer patients: a phase I-II study. Blood. 1994;84(5):1434-1441.
- 20. Vagdatli E, Gounari E, Lazaridou E, Katsibourlia E, Tsikopoulou F, Labrianou I. Platelet distribution width: a simple, practical and specific marker of activation of coagulation. Hippokratia. 2010;14(1):28-32.